{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:11:44Z","timestamp":1789726304366,"version":"4.0.1"},"reference-count":27,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:title>abstract<\/jats:title><jats:sec><jats:title>Context:<\/jats:title><jats:p>Hypercalcemia in ambulatory patients is occasionally caused by vitamin D toxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>We report nine patients presenting to Columbia University Medical Center with hypercalcemia due to a supplement from the Dominican Republic containing massive amounts of vitamin D.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Case histories and laboratory evaluation (calcium, PTH, vitamin D metabolites) are discussed in the context of other published cases of vitamin D toxicity. The supplement was analyzed by HPLC to quantitate vitamin D and A content.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Nine patients presented with hypercalcemia (range, 10.8\u201317.2 mg\/dl; normal, 8.4\u20139.8 mg\/dl), suppressed PTH (range, &amp;lt;3 to 11 pg\/ml), and elevated 25-hydroxyvitamin D (range, 94\u2013525 ng\/ml; normal, 30\u201380 ng\/ml) levels. All reported recently taking an over-the-counter vitamin supplement called Soladek readily available in the Dominican Republic and in Upper Manhattan. Although serum calcium values before the ingestion of Soladek were not elevated (baseline serum calcium range, 8.7\u20139.2 mg\/dl), most had a disorder that can be associated with hypercalcemia [squamous cell cancer (n = 1), Pneumocystis or mycobacterial infection (n = 3), lymphoma (n = 1), granulomatous disease (n = 1), hyperthyroidism (n = 2)]. According to the manufacturer's label, each 5-ml vial of Soladek contains vitamin D (600,000 IU), vitamin A (120,000 IU), and vitamin E (5 mg). Laboratory analysis by HPLC revealed that the supplement actually contained vitamin D3 (864,000 IU) and vitamin A (predominantly retinyl palmitate 123,500 IU) per vial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Although hypercalcemia due to exogenous use of vitamin D is unusual, it is important to consider it in the differential diagnosis, particularly among individuals with access to Soladek.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2010-1999","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T05:34:26Z","timestamp":1291268066000},"page":"291-295","source":"Crossref","is-referenced-by-count":59,"title":["Vitamin D Toxicity due to a Commonly Available \u201cOver the Counter\u201d Remedy from the Dominican Republic"],"prefix":"10.1210","volume":"96","author":[{"given":"Hyesoo","family":"Lowe","sequence":"first","affiliation":[{"name":"Division of Endocrinology (H.L., N.E.C., J.P.B.), Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Cusano","sequence":"additional","affiliation":[{"name":"Division of Endocrinology (H.L., N.E.C., J.P.B.), Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[{"name":"Department of Medicine (N.B.), University of Wisconsin Osteoporosis Research Program, University of Wisconsin-Madison, Madison, Wisconsin 53706;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Blaner","sequence":"additional","affiliation":[{"name":"Institute of Human Nutrition (W.S.B.), College of Physicians and Surgeons, Columbia University, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[{"name":"Division of Endocrinology (H.L., N.E.C., J.P.B.), Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071622544010300_B1","unstructured":"2008 National Institutes of Health Office of Dietary Supplements. http:\/\/ods.od.nih.gov\/Health_Information\/Vitamin_and_Mineral_Supplement_Fact_sheets.aspx"},{"key":"2020071622544010300_B2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0169-6009(90)90023-9","article-title":"The mechanisms of vitamin D toxicity.","volume":"11","author":"Vieth","year":"1990","journal-title":"Bone Miner"},{"key":"2020071622544010300_B3","doi-asserted-by":"crossref","first-page":"582S","DOI":"10.1093\/ajcn\/88.2.582S","article-title":"Pharmacokinetics of vitamin D toxicity.","volume":"88","author":"Jones","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"2020071622544010300_B4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1359\/JBMR.0301257","article-title":"CYP3A4 is a human microsomal vitamin D 25-hydroxylase.","volume":"19","author":"Gupta","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2020071622544010300_B5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.1982.03320310085047","article-title":"Metabolites and analogs of vitamin D: which for what?","volume":"247","author":"Haussler","year":"1982","journal-title":"JAMA"},{"key":"2020071622544010300_B6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jbmr.5650091219","article-title":"Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.","volume":"9","author":"Uchida","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2020071622544010300_B7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00000441-199311000-00008","article-title":"Case report: hypercalcemia in a patient with AIDS and Pneumocystis carinii pneumonia.","volume":"306","author":"Ahmed","year":"1993","journal-title":"Am J Med Sci"},{"key":"2020071622544010300_B8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1742-1241.1999.tb11710.x","article-title":"Hypercalcaemia: a clue to Mycobacterium avium intracellulare infection in a patient with AIDS.","volume":"53","author":"Aly","year":"1999","journal-title":"Int J Clin Pract"},{"key":"2020071622544010300_B9","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1053\/ajkd.2002.30578","article-title":"Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia.","volume":"39","author":"Chen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2020071622544010300_B10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/01.tp.0000185461.21901.5b","article-title":"Pneumocystis carinii pneumonia with hypercalcemia and suppressed parathyroid hormone levels in a renal transplant patient.","volume":"81","author":"Hung","year":"2006","journal-title":"Transplantation"},{"key":"2020071622544010300_B11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/jinf.2000.0767","article-title":"Hypercalcaemia and elevated 1,25(OH)(2)D(3) levels associated with disseminated Mycobacterium avium infection in AIDS.","volume":"42","author":"Playford","year":"2001","journal-title":"J Infect"},{"key":"2020071622544010300_B12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood.V73.1.235.235","article-title":"Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma.","volume":"73","author":"Adams","year":"1989","journal-title":"Blood"},{"key":"2020071622544010300_B13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/00007611-199909000-00017","article-title":"Hypercalcemia as an early sign of lymphoma in a patient with acquired immunodeficiency syndrome (AIDS).","volume":"92","author":"Al-Tawfiq","year":"1999","journal-title":"South Med J"},{"key":"2020071622544010300_B14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1742-1241.2004.00055.x","article-title":"Symptomatic hypercalcemia as presenting manifestation of lymphoma in a patient with acquired immunodeficiency syndrome.","volume":"58","author":"Lydakis","year":"2004","journal-title":"Int J Clin Pract"},{"key":"2020071622544010300_B15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/endo.134.1.8275930","article-title":"Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.","volume":"134","author":"Britto","year":"1994","journal-title":"Endocrinology"},{"key":"2020071622544010300_B16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4158\/EP.3.6.357","article-title":"Hypercalcemia due to subacute thyroiditis.","volume":"3","author":"Kaye","year":"1997","journal-title":"Endocr Pract"},{"key":"2020071622544010300_B17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI108497","article-title":"Direct stimulation of bone resorption by thyroid hormones.","volume":"58","author":"Mundy","year":"1976","journal-title":"J Clin Invest"},{"key":"2020071622544010300_B18","first-page":"917","article-title":"Unusual cases of chronic intoxication by vitamin D.","volume":"16","author":"Chiricone","year":"2003","journal-title":"J Nephrol"},{"key":"2020071622544010300_B19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJMc063341","article-title":"Dietary supplement-induced vitamin D intoxication.","volume":"357","author":"Klontz","year":"2007","journal-title":"N Engl J Med"},{"key":"2020071622544010300_B20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1056\/NEJM200107053450115","article-title":"Vitamin D intoxication associated with an over-the-counter supplement.","volume":"345","author":"Koutkia","year":"2001","journal-title":"N Engl J Med"},{"key":"2020071622544010300_B21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2105\/AJPH.85.5.656","article-title":"An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy.","volume":"85","author":"Blank","year":"1995","journal-title":"Am J Public Health"},{"key":"2020071622544010300_B22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199204303261801","article-title":"Hypervitaminosis D associated with drinking milk.","volume":"326","author":"Jacobus","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071622544010300_B23","first-page":"654","article-title":"Abstracts of the 2006 North American Congress of Clinical Toxicology Annual Meeting.","volume":"44","author":"Schwaner","year":"2006","journal-title":"Clin Toxicol"},{"key":"2020071622544010300_B24","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4158\/EP.14.9.1188","article-title":"Vitamin D toxicity: caveat emptor.","volume":"14","author":"Leu","year":"2008","journal-title":"Endocr Pract"},{"key":"2020071622544010300_B25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial.","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"2020071622544010300_B26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jada.2004.10.006","article-title":"Hypercalcemia caused by iatrogenic hypervitaminosis A.","volume":"105","author":"Bhalla","year":"2005","journal-title":"J Am Diet Assoc"},{"key":"2020071622544010300_B27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ar.1091580408","article-title":"Alpharadiographic and histological observations on the skeletal effects of hypervitaminoses A and D in the rat.","volume":"158","author":"B\u00e9langer","year":"1967","journal-title":"Anat Rec"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/96\/2\/291\/9067108\/jcem0291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/96\/2\/291\/9067108\/jcem0291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T10:18:40Z","timestamp":1685873920000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/96\/2\/291\/2709490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-1999","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,1]]}}}